Xiaoping Yan
Overview
Explore the profile of Xiaoping Yan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
233
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu X, Li D, Zheng Y, Ma Y, Yan X, Zhou Q, et al.
Insects
. 2025 Feb;
16(2).
PMID: 40003839
Accurate, rapid, and intelligent stored-grain insect detection and counting are important for integrated pest management (IPM). Existing stored-grain insect pest detection models are often not suitable for detecting tiny insects...
2.
Yan X, Wang J, Chen C, Zheng K, Zhang P, Shen C
Molecules
. 2024 Oct;
29(20).
PMID: 39459182
A biomass-based catalyst, CuO@CS-400, was employed as an excellent recyclable heterogeneous catalyst to realize the sulfonylation reaction of aniline derivatives with sodium sulfinates. Various substrates were compatible, giving the desired...
3.
Shao C, Yan X, Li H, Nian D, Ren L, Pang S, et al.
Mol Pharm
. 2024 Jul;
21(9):4259-4271.
PMID: 39077844
Radioimmunotherapy (RIT) is a novel and promising cancer treatment method, with ongoing research focusing on RIT antibody selection, radionuclides, treatment options, and benefited patient groups. As we dive into the...
4.
Tang L, Cheng Q, Qing Y, Yu J, Yan X, Liao C
Int Wound J
. 2024 Mar;
21(4):e14800.
PMID: 38546145
Peritoneal dialysis(PD) is one of the most efficient methods in end-stage kidney disease, and it is very important for PD to perform well. No research has been conducted to evaluate...
5.
Shao C, Yan X, Pang S, Nian D, Ren L, Li H, et al.
Int Immunopharmacol
. 2024 Mar;
130:111781.
PMID: 38442580
Purpose: Immune checkpoint inhibitors (ICIs) targeting tumor-specific PD-1/PD-L1 significantly improve the overall survival rate of patients with advanced cancer by reactivating the immune system to attack cancer cells. To explore...
6.
Sun W, Mu W, Jefferies C, Learch T, Ishimori M, Wu J, et al.
PeerJ
. 2023 Nov;
11:e16448.
PMID: 38025753
Background: To analyze individually and interactively critical risk factors, which are closely related to low bone mineral density (BMD) in patient with ankylosing spondylitis (AS). Methods: A total of 249...
7.
Qiu Y, Yan X, Ma H, Wang Y, Yang R, Opedal O, et al.
Evol Appl
. 2023 May;
16(4):814-823.
PMID: 37124085
The ecological effects of mass-flowering crops on pollinator abundance and species richness of neighbouring habitats are well established, yet the potential evolutionary consequences remain unclear. We studied effects of proximity...
8.
Kong W, Tang Y, Tang K, Yan Z, Liu T, Tao Q, et al.
Int J Rheum Dis
. 2022 Mar;
25(5):592-600.
PMID: 35238474
Aim: Ankylosing spondylitis (AS) is a chronic inflammatory disease. However, the key inflammatory cytokines disrupted in this disease are not well defined. In this study, we performed protein array and...
9.
Kong W, Jefferies C, Learch T, Gan X, Zhu F, Zhang N, et al.
J Clin Rheumatol
. 2021 Jan;
28(1):e118-e124.
PMID: 33394829
Objectives: A cross-sectional study was conducted in 270 Chinese patients with ankylosing spondylitis (AS) in order to identify potential risk factors for severity of spinal structural damage. Methods: Two hundred...
10.
Jing W, Sun W, Zhang N, Zhao C, Yan X
Eur J Pharmacol
. 2019 Sep;
865:172663.
PMID: 31539553
Rheumatoid arthritis (RA) is a common immune-mediated chronic inflammatory joint disease of unknown etiology. While tumor necrosis factor-α(TNF-α) blockers have proven to be a beneficial treatment option for many patients,...